ClinicalTrials.govpublic full text
Early Response Evaluation in NSCLC Patients Treated With Immunotherapy
nsclc, stage iv, pd-l1 expression, eligible for treatment with nivolumab, interventional, na
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 992271
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.